Description:

AMC-045 Chemistries, LFT's (F23) Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer https://clinicaltrials.gov/ct2/show/NCT00324415

Link:

https://clinicaltrials.gov/ct2/show/NCT00324415

Keywords:

Laboratories

Clinical Trial

Chemistry

Anus Neoplasms

Versions (2) ▾

8/26/12
6/9/17

Uploaded on:

June 9, 2017

DOI:

No DOI assigned. To request one pleaselog in.

License:

Creative Commons BY-NC 3.0

Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

HIV Anal Cancer Therapy NCT00324415 AMC-045

Details

No Instruction available.

StudyEvent: AMC-045 Chemistries, LFT's (F23)
1. No Instruction available.

Header Module

Visit number

Sequence number

Date of evaluation

mm/dd/yyyy

Reporting Period (select one)

Baseline (Baseline)

On Treatment (On treatment)

Post-therapy (Post therapy)

Comments

Ccrr Module For Chemistries, Lft's - Rf23

Sodium (mEq/L)

mmol/L

Potassium (mEq/L)

mmol/L

Chloride (mEq/L)

mEq/L

Magnesium

mmol/L

Bicarbonate (mEq/L)

mEq/L

Alkaline Phosphatase (mU/ml)

SGOT (AST)

mU/ml

SGPT (ALT)

mU/ml

BUN

mg/dl

Creatinine

mg/dL

Total Bilirubin

mg/dl

Indirect Bilirubin

mg/dl

Albumin

g/dl

Other, specify test

Back to the top of the page

Contact

Please use this form for feedback, questions and suggestions for improvements.